Market Cap 359.06M
Revenue (ttm) 18.67M
Net Income (ttm) -64.78M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -346.97%
Debt to Equity Ratio 0.00
Volume 611,000
Avg Vol 737,870
Day's Range N/A - N/A
Shares Out 144.78M
Stochastic %K 4%
Beta 0.42
Analysts Strong Sell
Price Target $7.33

Company Profile

OmniAb, Inc., a biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada. The company's technology platform creates and screens diverse antibody repertoires to identify optimal antibodies and other target-binding proteins for partners' drug development efforts. Its OmniAb platform's Biological Intelligence powers the immune systems...

Industry: Biotechnology
Sector: Healthcare
Phone: 510 250 7800
Address:
5980 Horton Street, Suite 600, EmeryVille, United States
PlannedTrading101
PlannedTrading101 Jun. 4 at 4:51 PM
0 · Reply
PlannedTrading101
PlannedTrading101 May. 22 at 3:20 PM
$OABI Still Holding! Chart going as expected. Updated chart.
0 · Reply
PlannedTrading101
PlannedTrading101 May. 20 at 10:23 PM
0 · Reply
NVDAMillionaire
NVDAMillionaire May. 19 at 7:51 PM
$OABI Brilliant piece that captures OABI's situation perfectly. So if you want to update your understanding of OABI or get to know OABI better, this is essential reading. https://everyticker.com/quote/OABI/analysis/omniab-s-clinical-pipeline-inflection-why-biological-intelligence-creates-a-scalable-royalty-machine-nasdaq-oabi
0 · Reply
belugatrade
belugatrade May. 15 at 2:59 PM
$OABI what a pretty bottom reversal.
0 · Reply
PlannedTrading101
PlannedTrading101 May. 14 at 5:39 PM
$OABI At resistance. I think we push past it this time!
0 · Reply
PlannedTrading101
PlannedTrading101 May. 14 at 3:16 PM
$OABI Updated chart
0 · Reply
PlannedTrading101
PlannedTrading101 May. 14 at 3:10 PM
$OABI 🚨 Breaking out!!! 🚨
0 · Reply
PlannedTrading101
PlannedTrading101 May. 14 at 12:23 AM
$OABI 3 - 6 -10
0 · Reply
PlannedTrading101
PlannedTrading101 May. 14 at 12:21 AM
$OABI don’t understand how this is still under the radar!!! We are early for those of you who have been accumulating. Will only go up from here IMO. I think this could head back to IPO $10 and more. 🚨
0 · Reply
Latest News on OABI
OmniAb reports Q1 EPS (6c), consensus (10c)

2026-05-07T22:45:24.000Z - 4 weeks ago

OmniAb reports Q1 EPS (6c), consensus (10c)


OmniAb Earnings Call Transcript: Q1 2026

May 7, 2026, 4:30 PM EDT - 4 weeks ago

OmniAb Earnings Call Transcript: Q1 2026


OmniAb Slides: Q1 2026

May 7, 2026, 4:30 PM EDT - 4 weeks ago

OmniAb Slides: Q1 2026


OmniAb Earnings release: Q1 2026

May 7, 2026, 4:30 PM EDT - 4 weeks ago

OmniAb Earnings release: Q1 2026


OmniAb Quarterly report: Q1 2026

May 7, 2026, 4:30 PM EDT - 4 weeks ago

OmniAb Quarterly report: Q1 2026


OmniAb Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 5 weeks ago

OmniAb Proxy statement: Proxy filing


OmniAb Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 5 weeks ago

OmniAb Proxy statement: Proxy filing


OmniAb to Participate in Three Upcoming Investor Conferences

Apr 24, 2026, 8:00 AM EDT - 6 weeks ago

OmniAb to Participate in Three Upcoming Investor Conferences


OmniAb to Report First Quarter 2026 Financial Results on May 7

Apr 21, 2026, 8:00 AM EDT - 6 weeks ago

OmniAb to Report First Quarter 2026 Financial Results on May 7


OmniAb Slides: Corporate presentation

Mar 9, 2026, 7:00 AM EDT - 3 months ago

OmniAb Slides: Corporate presentation


OmniAb Earnings Call Transcript: Q4 2025

Mar 4, 2026, 4:30 PM EST - 3 months ago

OmniAb Earnings Call Transcript: Q4 2025


OmniAb Annual report: Q4 2025

Mar 4, 2026, 4:30 PM EST - 3 months ago

OmniAb Annual report: Q4 2025


OmniAb Earnings release: Q4 2025

Mar 4, 2026, 4:30 PM EST - 3 months ago

OmniAb Earnings release: Q4 2025


OmniAb Slides: Q4 2025

Mar 4, 2026, 4:30 PM EST - 3 months ago

OmniAb Slides: Q4 2025


OmniAb reports Q4 EPS (11c), consensus (9c)

2026-03-04T21:21:33.000Z - 3 months ago

OmniAb reports Q4 EPS (11c), consensus (9c)


OmniAb sees FY26 revenue $25M-$30M, consensus $32M

2026-03-04T21:21:03.000Z - 3 months ago

OmniAb sees FY26 revenue $25M-$30M, consensus $32M


OmniAb Transcript: Investor Update

Dec 15, 2025, 5:00 PM EST - 6 months ago

OmniAb Transcript: Investor Update


OmniAb Press release: Investor Update

Dec 15, 2025, 5:00 PM EST - 6 months ago

OmniAb Press release: Investor Update


OmniAb Slides: Investor Update

Dec 15, 2025, 5:00 PM EST - 6 months ago

OmniAb Slides: Investor Update


OmniAb management to meet virtually with Craig-Hallum

2025-12-15T14:55:08.000Z - 6 months ago

OmniAb management to meet virtually with Craig-Hallum


OmniAb to Hold OmniUltra Virtual Investor Event on December 15

Dec 4, 2025, 4:05 PM EST - 6 months ago

OmniAb to Hold OmniUltra Virtual Investor Event on December 15


OmniAb price target lowered to $7 from $10 at Craig-Hallum

2025-11-05T14:22:39.000Z - 7 months ago

OmniAb price target lowered to $7 from $10 at Craig-Hallum


OmniAb Earnings Call Transcript: Q3 2025

Nov 4, 2025, 4:30 PM EST - 7 months ago

OmniAb Earnings Call Transcript: Q3 2025


OmniAb Quarterly report: Q3 2025

Nov 4, 2025, 4:30 PM EST - 7 months ago

OmniAb Quarterly report: Q3 2025


OmniAb Earnings release: Q3 2025

Nov 4, 2025, 4:30 PM EST - 7 months ago

OmniAb Earnings release: Q3 2025


OmniAb Slides: Q3 2025

Nov 4, 2025, 4:30 PM EST - 7 months ago

OmniAb Slides: Q3 2025


OmniAb reports Q3 EPS (14c), consensus (14c)

2025-11-04T21:20:48.000Z - 7 months ago

OmniAb reports Q3 EPS (14c), consensus (14c)


OmniAb sees FY25 revenue $18M-$22M, consensus $21.7M

2025-11-04T21:20:37.000Z - 7 months ago

OmniAb sees FY25 revenue $18M-$22M, consensus $21.7M


OmniAb to Participate in Three Investor Conferences in November

Oct 16, 2025, 8:00 AM EDT - 8 months ago

OmniAb to Participate in Three Investor Conferences in November


OmniAb files to sell 21.25M shares of common stock for holders

2025-09-12T20:05:15.000Z - 9 months ago

OmniAb files to sell 21.25M shares of common stock for holders


OmniAb Registration statement: Registration Filing

Sep 12, 2025, 8:00 AM EDT - 9 months ago

OmniAb Registration statement: Registration Filing


OmniAb to sell 21.254M shares at $1.40 in private placement

2025-08-25T11:10:11.000Z - 10 months ago

OmniAb to sell 21.254M shares at $1.40 in private placement


OmniAb Announces $30 Million Private Placement

Aug 25, 2025, 7:00 AM EDT - 10 months ago

OmniAb Announces $30 Million Private Placement


OmniAb Earnings Call Transcript: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 10 months ago

OmniAb Earnings Call Transcript: Q2 2025


OmniAb Quarterly report: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 10 months ago

OmniAb Quarterly report: Q2 2025


OmniAb Earnings release: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 10 months ago

OmniAb Earnings release: Q2 2025


OmniAb Slides: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 10 months ago

OmniAb Slides: Q2 2025


OmniAb reports Q2 EPS (15c), consensus (15c)

2025-08-06T20:28:37.000Z - 10 months ago

OmniAb reports Q2 EPS (15c), consensus (15c)


OmniAb to Report Second Quarter 2025 Financial Results on August 6

Jul 16, 2025, 8:00 AM EDT - 11 months ago

OmniAb to Report Second Quarter 2025 Financial Results on August 6


OmniAb Earnings Call Transcript: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

OmniAb Earnings Call Transcript: Q1 2025


OmniAb Quarterly report: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

OmniAb Quarterly report: Q1 2025


OmniAb Earnings release: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

OmniAb Earnings release: Q1 2025


OmniAb Slides: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

OmniAb Slides: Q1 2025


OmniAb reports Q1 EPS (17c), consensus (17c)

2025-05-08T20:29:10.000Z - 1 year ago

OmniAb reports Q1 EPS (17c), consensus (17c)


OmniAb backs FY25 revenue view $20M-$25M, consensus $23.03M

2025-05-08T20:28:12.000Z - 1 year ago

OmniAb backs FY25 revenue view $20M-$25M, consensus $23.03M


OmniAb Introduces the xPloration® Partner Access Program

May 8, 2025, 4:05 PM EDT - 1 year ago

OmniAb Introduces the xPloration® Partner Access Program


OmniAb to Participate in Five Upcoming Investor Conferences

May 1, 2025, 8:00 AM EDT - 1 year ago

OmniAb to Participate in Five Upcoming Investor Conferences


OmniAb Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

OmniAb Proxy statement: Proxy Filing


OmniAb Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

OmniAb Proxy statement: Proxy Filing


OmniAb management to meet with Truist

2025-04-17T11:50:09.000Z - 1 year ago

OmniAb management to meet with Truist


OmniAb price target lowered to $4 from $7 at RBC Capital

2025-03-27T12:16:16.000Z - 1 year ago

OmniAb price target lowered to $4 from $7 at RBC Capital


OmniAb price target lowered to $4 from $8 at TD Cowen

2025-03-21T13:46:09.000Z - 1 year ago

OmniAb price target lowered to $4 from $8 at TD Cowen


OmniAb price target lowered to $6 from $8 at Benchmark

2025-03-20T11:22:35.000Z - 1 year ago

OmniAb price target lowered to $6 from $8 at Benchmark


OmniAb Earnings Call Transcript: Q4 2024

Mar 18, 2025, 4:30 PM EDT - 1 year ago

OmniAb Earnings Call Transcript: Q4 2024


OmniAb Annual report: Q4 2024

Mar 18, 2025, 4:30 PM EDT - 1 year ago

OmniAb Annual report: Q4 2024


OmniAb Earnings release: Q4 2024

Mar 18, 2025, 4:30 PM EDT - 1 year ago

OmniAb Earnings release: Q4 2024


OmniAb Slides: Q4 2024

Mar 18, 2025, 4:30 PM EDT - 1 year ago

OmniAb Slides: Q4 2024


OmniAb sees FY25 revenue $20M-$25M, consensus $45.98M

2025-03-18T20:16:47.000Z - 1 year ago

OmniAb sees FY25 revenue $20M-$25M, consensus $45.98M


OmniAb to Participate in Two Investor Conferences in March

Feb 3, 2025, 4:57 PM EST - 1 year ago

OmniAb to Participate in Two Investor Conferences in March


OmniAb Earnings Call Transcript: Q3 2024

Nov 12, 2024, 4:30 PM EST - 1 year ago

OmniAb Earnings Call Transcript: Q3 2024


OmniAb Quarterly report: Q3 2024

Nov 12, 2024, 4:30 PM EST - 1 year ago

OmniAb Quarterly report: Q3 2024


OmniAb Earnings release: Q3 2024

Nov 12, 2024, 4:30 PM EST - 1 year ago

OmniAb Earnings release: Q3 2024


OmniAb Slides: Q3 2024

Nov 12, 2024, 4:30 PM EST - 1 year ago

OmniAb Slides: Q3 2024


OmniAb to Participate in Two Investor Conferences in November

Oct 30, 2024, 8:00 AM EDT - 1 year ago

OmniAb to Participate in Two Investor Conferences in November


OmniAb Earnings Call Transcript: Q2 2024

Aug 8, 2024, 4:30 PM EDT - 1 year ago

OmniAb Earnings Call Transcript: Q2 2024


OmniAb Quarterly report: Q2 2024

Aug 8, 2024, 4:30 PM EDT - 1 year ago

OmniAb Quarterly report: Q2 2024


OmniAb Earnings release: Q2 2024

Aug 8, 2024, 4:30 PM EDT - 1 year ago

OmniAb Earnings release: Q2 2024


OmniAb Slides: Q2 2024

Aug 8, 2024, 4:30 PM EDT - 1 year ago

OmniAb Slides: Q2 2024


OmniAb Transcript: Jefferies Global Healthcare Conference

Jun 5, 2024, 8:00 AM EDT - 2 years ago

OmniAb Transcript: Jefferies Global Healthcare Conference


OmniAb Earnings Call Transcript: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

OmniAb Earnings Call Transcript: Q1 2024


OmniAb Quarterly report: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

OmniAb Quarterly report: Q1 2024


OmniAb Earnings release: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

OmniAb Earnings release: Q1 2024


OmniAb Slides: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

OmniAb Slides: Q1 2024


OmniAb to Participate in Five Investor Conferences in May

May 1, 2024, 8:00 AM EDT - 2 years ago

OmniAb to Participate in Five Investor Conferences in May


OmniAb Proxy statement: Proxy Filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

OmniAb Proxy statement: Proxy Filing


OmniAb Proxy statement: Proxy Filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

OmniAb Proxy statement: Proxy Filing


OmniAb to Report First Quarter 2024 Financial Results on May 9

Apr 22, 2024, 8:00 AM EDT - 2 years ago

OmniAb to Report First Quarter 2024 Financial Results on May 9


OmniAb Earnings Call Transcript: Q4 2023

Mar 20, 2024, 4:30 PM EDT - 2 years ago

OmniAb Earnings Call Transcript: Q4 2023


OmniAb Annual report: Q4 2023

Mar 20, 2024, 4:30 PM EDT - 2 years ago

OmniAb Annual report: Q4 2023


OmniAb Earnings release: Q4 2023

Mar 20, 2024, 4:30 PM EDT - 2 years ago

OmniAb Earnings release: Q4 2023


OmniAb Slides: Q4 2023

Mar 20, 2024, 4:30 PM EDT - 2 years ago

OmniAb Slides: Q4 2023


OmniAb Registration statement: Registration Filing

Dec 8, 2023, 7:00 AM EST - 2 years ago

OmniAb Registration statement: Registration Filing


OmniAb Earnings Call Transcript: Q3 2023

Nov 9, 2023, 11:00 AM EST - 2 years ago

OmniAb Earnings Call Transcript: Q3 2023


OmniAb Quarterly report: Q3 2023

Nov 9, 2023, 11:00 AM EST - 2 years ago

OmniAb Quarterly report: Q3 2023


OmniAb Earnings release: Q3 2023

Nov 9, 2023, 11:00 AM EST - 2 years ago

OmniAb Earnings release: Q3 2023


OmniAb Slides: Q3 2023

Nov 9, 2023, 11:00 AM EST - 2 years ago

OmniAb Slides: Q3 2023


OmniAb Appoints Steve Love to its Board of Directors

Nov 1, 2023, 9:00 AM EDT - 2 years ago

OmniAb Appoints Steve Love to its Board of Directors


OmniAb Earnings Call Transcript: Q2 2023

Aug 10, 2023, 4:30 PM EDT - 3 years ago

OmniAb Earnings Call Transcript: Q2 2023


OmniAb Quarterly report: Q2 2023

Aug 10, 2023, 4:30 PM EDT - 3 years ago

OmniAb Quarterly report: Q2 2023


OmniAb Earnings release: Q2 2023

Aug 10, 2023, 4:30 PM EDT - 3 years ago

OmniAb Earnings release: Q2 2023


OmniAb Slides: Q2 2023

Aug 10, 2023, 4:30 PM EDT - 3 years ago

OmniAb Slides: Q2 2023


OmniAb Announces the Passing of Director Sunil Patel

Aug 7, 2023, 4:05 PM EDT - 3 years ago

OmniAb Announces the Passing of Director Sunil Patel


PlannedTrading101
PlannedTrading101 Jun. 4 at 4:51 PM
0 · Reply
PlannedTrading101
PlannedTrading101 May. 22 at 3:20 PM
$OABI Still Holding! Chart going as expected. Updated chart.
0 · Reply
PlannedTrading101
PlannedTrading101 May. 20 at 10:23 PM
0 · Reply
NVDAMillionaire
NVDAMillionaire May. 19 at 7:51 PM
$OABI Brilliant piece that captures OABI's situation perfectly. So if you want to update your understanding of OABI or get to know OABI better, this is essential reading. https://everyticker.com/quote/OABI/analysis/omniab-s-clinical-pipeline-inflection-why-biological-intelligence-creates-a-scalable-royalty-machine-nasdaq-oabi
0 · Reply
belugatrade
belugatrade May. 15 at 2:59 PM
$OABI what a pretty bottom reversal.
0 · Reply
PlannedTrading101
PlannedTrading101 May. 14 at 5:39 PM
$OABI At resistance. I think we push past it this time!
0 · Reply
PlannedTrading101
PlannedTrading101 May. 14 at 3:16 PM
$OABI Updated chart
0 · Reply
PlannedTrading101
PlannedTrading101 May. 14 at 3:10 PM
$OABI 🚨 Breaking out!!! 🚨
0 · Reply
PlannedTrading101
PlannedTrading101 May. 14 at 12:23 AM
$OABI 3 - 6 -10
0 · Reply
PlannedTrading101
PlannedTrading101 May. 14 at 12:21 AM
$OABI don’t understand how this is still under the radar!!! We are early for those of you who have been accumulating. Will only go up from here IMO. I think this could head back to IPO $10 and more. 🚨
0 · Reply
PlannedTrading101
PlannedTrading101 May. 13 at 6:18 PM
$OABI On the money. Still lots of room to go!
0 · Reply
WeighProtein
WeighProtein May. 12 at 9:17 PM
$OABI Might look into shorting this 🙃
2 · Reply
PlannedTrading101
PlannedTrading101 May. 12 at 5:13 PM
$OABI Price Targets:
0 · Reply
PlannedTrading101
PlannedTrading101 May. 12 at 4:57 PM
$OABI Print baby, print! 2.50+
0 · Reply
MarketBeat
MarketBeat May. 8 at 8:03 PM
OmniAb Q1 Earnings Call Highlights $OABI #OmniAb #instantalerts #NASDAQ:OABI https://www.marketbeat.com/instant-alerts/omniab-q1-earnings-c
0 · Reply
PlannedTrading101
PlannedTrading101 May. 8 at 2:29 PM
$OABI Just starting! 🔥
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 7 at 8:23 PM
$OABI Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.06 up 64.71% YoY • Reported revenue of $14.43M up 247.30% YoY • OmniAb raised 2026 revenue guidance to $28M-$33M from $25M-$30M. Costs and operating expenses are now expected between $83M-$88M, up from $80M-$85M. Cash and cash equivalents guidance was also raised to $33M-$38M.
0 · Reply
PlannedTrading101
PlannedTrading101 May. 7 at 5:35 PM
$OABI At Support area. Holding for 2.50+. Long here.
1 · Reply
SuperGreenToday
SuperGreenToday May. 6 at 3:20 PM
$OABI Share Price: $1.39 Contract Selected: Oct 16, 2026 $2.5 Calls Buy Zone: $0.08 – $0.09 Target Zone: $0.14 – $0.17 Potential Upside: 68% ROI Time to Expiration: 162 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
a36er
a36er May. 3 at 3:16 PM
$OABI Alright board. It's going to be a pretty interesting week coming up for this little security. Here's my dumb take behind OmniAB right now- The thinking behind AI being an adversary to animal testing is the wrong approach (in the short to intermediate timeframe). Smaller transgenic animal testing companies such as OmniAB are now potential acquisition targets (or at least partner candidates) for these AI companies so that the work can be proofed and checked. The drug discovery industry moves at a snail's pace regarding regulations and I see OmniAB's assets as synergies to a company developing these new discovery platforms. This might be Gotham's view as well who knows. Volume has steadily been increasing for months, and the market cap tells me this will be a deSPAC that actually makes it down the road. Only hold up I have for really big immanent moves is the warrant price action has gone to the graveyard. The real boat anchor here is the potential for more equity offerings.
0 · Reply
PlannedTrading101
PlannedTrading101 May. 1 at 5:22 PM
$OABI Been accumulating. Looking to add more down here in this range. Anything below 1.40 is a steal IMO.
1 · Reply
bearsoil
bearsoil Apr. 29 at 10:33 PM
$OABI All in all with three presentations set up next month I doubt there would be any imminent major disappointing news on the horizon. Averging down
0 · Reply